Full year trading and operational update

Summary by AI BETAClose X

Directa Plus plc expects to report full-year revenues of €7.0m for 2025, an increase from €6.66m in 2024, with adjusted LBITDA broadly in line with market expectations of approximately €2.5m, reflecting disciplined cost control and operational efficiencies. The company has made advances in production technology, broadening its portfolio to address high-growth applications, and has achieved significant cost savings of at least €0.7m annually from restructuring initiatives at Setcar. Setcar also secured a €1.5m Total Waste Management contract with Ford and is evaluating the sale of non-strategic land valued at approximately €0.5m. The Group ended 2025 with €1.5m in gross cash balances and anticipates needing requisite funding in 2026 to support future growth, with the Board exploring options to monetize its intellectual property. Non-Executive Chairman Richard Hickinbotham will step down on January 31, 2026, with Giulio Cesareo assuming the role of Interim plc Chairman.

Disclaimer*

Directa Plus PLC
07 January 2026
 

7 January 2026

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

 

Full year trading and operational update

 Board change

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces an update on trading for the year ended 31 December 2025 ("FY25").

 

The Group expects to report, subject to audit, revenues of €7.0m (FY24: €6.66m) and adjusted LBITDA for the year broadly in line with market expectations of approximately €2.5m (FY24: €3.64m), reflecting c.30% improvement year on year, underpinned by disciplined cost control and operational efficiencies.

 

Production optimisation

The Group made advances in technology, production and product capabilities, strengthening its ability to manufacture advanced graphene-based materials at low cost, at scale and with highest levels of consistency. Production enhancements to develop interlocked and blended graphene materials have broadened the portfolio, further enabling the Group to address high-growth applications including PFAS-related fields, defence and highly regulated industrial sectors. These important development come at the time when interest in the graphene market is growing exponentially as market participants look to incorporate graphene into existing products and products road maps.

 

Setcar review and contract win

Management continues to focus on restructuring initiatives across Setcar, which has generated significant headcount reductions, operational efficiencies and margin improvements for at least €0.7m of annualised cost savings in FY25. Setcar is now better positioned to pursue opportunities within the strategically important Environmental Remediation market, underpinned by its technical expertise and extensive regulatory approvals.

 

In December 2025, Setcar won a competitive tender for a €1.5m Total Waste Management contract with Ford for a further 15 months. The company is now in the process of finalising the formal contract.

 

Work to deliver further efficiencies at Setcar is progressing and the Board will continue to evaluate the best options, improving overall capital allocation and how best to maximise shareholder value.

 

Separately, a process has commenced to realise the potential sale of non-strategic land held by Setcar, with an estimated value of at least €0.5m.

 

2026 Outlook

The Board is laser focused on capturing high-growth graphene-based opportunities, monetising Directa's core IP, which remains protected by a substantial patent portfolio.

 

The Board continues to evaluate its options to realise value from this portfolio, including partnerships, joint ventures and licensing, and to assess its optimum options to secure the requisite funding which will be needed in FY26 to support future growth.

 

The Group closed FY25 with gross cash balances of €1.5m (FY24: €4.98m), providing a solid financial base going forward. Entering FY26, Directa has a growing pipeline of opportunities across its targeted end markets, supported by advanced customer discussions, established product performance and increasing recognition of the value to customers from adopting Directa's technology and products.

 

Board changes

Richard Hickinbotham, Non-Executive Chairman, who would have shortly completed his nine-year tenure with the Group, has informed the Board of his intention to take up a full-time executive role and will step down from the Board on 31 January 2026. Giulio Cesareo will assume the role of Interim plc Chairman with effect from that date.

 

The CEO succession process, as previously announced, is being progressed and a further update will be provided in due course.

 

Giulio Cesareo, Chief Executive Officer at Directa Plus, said: "FY25 has been a year of transition for Directa. Alongside revenue growth and a significant improvement in EBITDA performance, we have strengthened our technology platform, sharpened our operational focus and taken decisive steps to improve efficiency across the Group. These actions have positioned us to better address high-growth, highly regulated markets where our graphene-based solutions have demonstrated clear added value. With a stronger balance sheet and a growing opportunity pipeline, we enter FY26 focused on execution, value creation and the disciplined monetisation of our core intellectual property and securing requisite founding that will be needed in FY26 to support our future growth.

 

"I would like to thank Richard Hickinbotham for his leadership over the past nine years and for the wise counsel and steadfast support he has provided throughout his tenure, particularly as we navigated a number of challenges. His contribution as Chairman has been invaluable, and we wish him every success in his new role."

 

For further information, please contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Giorgio Bonfanti, CFO

 

 


Singer Capital Markets (Nominated Adviser and Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies


 


Alma Strategic Communications (Financial PR Adviser)

+44 20 3405 0205

Justine James / Hannah Campbell / Rose Docherty

directaplus@almastrategic.com

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus's production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and past

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus's products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings